Kinetic and product distribution analysis of human eosinophil cationic protein indicates a subsite arrangement that favors exonuclease-type activity

被引:69
作者
Boix, E
Nikolovski, Z
Moiseyev, GP
Rosenberg, HF
Cuchillo, CM
Nogués, MV [1 ]
机构
[1] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Fac Ciencies, Bellaterra 08193, Spain
[2] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.274.22.15605
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
With the use of a high yield prokaryotic expression system, large amounts of human eosinophil cationic protein (ECP) have been obtained. This has allowed a thorough kinetic study of the ribonuclease activity of this protein. The catalytic efficiencies for oligouridylic acids of the type (Up)(n)U>p, mononucleotides U>p and C>p, and dinucleoside monophosphates CpA, UpA, and UpG have been interpreted by the specific subsites distribution in ECP, The distribution of products derived from digestion of high molecular mass substrates, such as poly(U) and poly(C), by ECP was compared with that of RNase A The characteristic cleavage pattern of polynucleotides by ECP suggests that an exonuclease-like mechanism is predominantly favored in comparison to the endonuclease catalytic mechanism of RNase A. Comparative molecular modeling with bovine pancreatic RNase A-substrate analog crystal complexes revealed important differences in the subsite structure, whereas the secondary phosphate-binding site (p(2)) is lacking, the secondary base subsite (B-2) is severely impaired, and there are new interactions at the p(o), B-o, and p(-1) sites, located upstream of the P-O-5' cleavable phosphodiester bond, that are not found in RNase A. The differences in the multisubsites structure could explain the reduced catalytic efficiency of ECP and the shift from an endonuclease to an exonuclease-type mechanism.
引用
收藏
页码:15605 / 15614
页数:10
相关论文
共 68 条
[1]   ICM - A NEW METHOD FOR PROTEIN MODELING AND DESIGN - APPLICATIONS TO DOCKING AND STRUCTURE PREDICTION FROM THE DISTORTED NATIVE CONFORMATION [J].
ABAGYAN, R ;
TOTROV, M ;
KUZNETSOV, D .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1994, 15 (05) :488-506
[2]   EOSINOPHIL GRANULE PROTEINS IN PERIPHERAL-BLOOD GRANULOCYTES [J].
ABUGHAZALEH, RI ;
DUNNETTE, SL ;
LOEGERING, DA ;
CHECKEL, JL ;
KITA, H ;
THOMAS, LL ;
GLEICH, GJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 52 (06) :611-618
[3]  
Ackerman Steven J., 1993, P33
[4]  
ALONSO J, 1986, ARCH BIOCHEM BIOPHYS, V246, P681, DOI 10.1016/0003-9861(86)90324-3
[5]   STRUCTURE OF SINGLE-STRANDED POLYRIBONUCLEOTIDE POLYCYTIDYLIC ACID [J].
ARNOTT, S ;
CHANDRASEKARAN, R ;
LESLIE, AGW .
JOURNAL OF MOLECULAR BIOLOGY, 1976, 106 (03) :735-748
[6]   AMINO-ACID SEQUENCE OF THE NONSECRETORY RIBONUCLEASE OF HUMAN-URINE [J].
BEINTEMA, JJ ;
HOFSTEENGE, J ;
IWAMA, M ;
MORITA, T ;
OHGI, K ;
IRIE, M ;
SUGIYAMA, RH ;
SCHIEVEN, GL ;
DEKKER, CA ;
GLITZ, DG .
BIOCHEMISTRY, 1988, 27 (12) :4530-4538
[7]  
BIRDSALL DL, 1992, J BIOL CHEM, V267, P22230
[8]  
BOIX E, 1994, J BIOL CHEM, V269, P2529
[9]   Role of the N terminus in RNase a homologues: Differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity [J].
Boix, E ;
Wu, YN ;
Vasandani, VM ;
Saxena, SK ;
Ardelt, W ;
Ladner, J ;
Youle, RJ .
JOURNAL OF MOLECULAR BIOLOGY, 1996, 257 (05) :992-1007
[10]   A VERSATILE NEGATIVE-STAINING RIBONUCLEASE ZYMOGRAM [J].
BRAVO, J ;
FERNANDEZ, E ;
RIBO, M ;
DELLORENS, R ;
CUCHILLO, CM .
ANALYTICAL BIOCHEMISTRY, 1994, 219 (01) :82-86